logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Letrozole CAS 112809-51-5

Letrozole CAS 112809-51-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 112809-51-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
112809-51-5
Appearance::
White To Off-white Crystalline Powder
Molecular Formula::
C17H11N5
Molecular Weight::
285.30300
EINECS NO::
675-034-8
MDL NO::
MFCD00866241
CAS NO::
112809-51-5
Appearance::
White To Off-white Crystalline Powder
Molecular Formula::
C17H11N5
Molecular Weight::
285.30300
EINECS NO::
675-034-8
MDL NO::
MFCD00866241
Letrozole CAS 112809-51-5

Product Description:

Product Name: Letrozole CAS NO: 112809-51-5

 

 

Synonyms:

4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis(benzonitrile);

UNII-7LKK855W8I;

4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;

 

 

Chemical & Physical Properties:

Appearance: White to off-white crystalline powder

Assay :≥99.0%

Density: 1.21g/cm3

Boiling Point: 374.4℃ at 760 mmHg

Melting Point: 181-183℃

Flash Point: 180.3℃

Storage Condition: Store in original container in a cool dark place.

 

 

Safety Information:

Safety Statements: S26; S36

HS Code: 2933990090

Risk Statements: R36/37/38

Hazard Codes: Xi; C

 

 

Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.